South China Prospective Cohort Study of Chronic Disease

September 12, 2017 updated by: Di Li, Sun Yat-sen University
To investigate the risk factors and prediction biomarkers of chronic disease in adults aged 35-74 years.

Study Overview

Status

Unknown

Conditions

Detailed Description

To investigate the risk factors and prediction biomarkers of chronic disease within adults aged 35-74 years in South China. Following up the incidence of major chronic disease including stroke, coronary heart disease, cancer, chronic obstructive pulmonary disease, diabetes and hypertension.

Study Type

Observational

Enrollment (Anticipated)

110000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510080
        • Recruiting
        • Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-Sen University (Northern Campus)
        • Contact:
        • Contact:
        • Principal Investigator:
          • Fan J Hua, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 74 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

aged 35-74 years local residents or lived in local for 5 years more,no gender perfomance

Description

Inclusion Criteria:

aged 35-74 years local residents or lived in local for 5 years more

Exclusion Criteria:

Malignancy Cognitive impairment that can not cooperate with investigation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of chronic disease
Time Frame: 4 years or more
Incidence of chronic disease, including stroke, coronary heart disease, cancer, chronic obstructive pulmonary disease, diabetes and hypertension
4 years or more

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outcome of chronic disease
Time Frame: 4 years or more
Outcome and development of chronic disease
4 years or more
Death
Time Frame: 4 years or more
Death caused by chronic disease
4 years or more
Incidence of other disease
Time Frame: 4 years or more
Incidence of other disease,including hyperuricaemia,fatty liver disease and so on
4 years or more

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fan J Hua, Ph.D, School of Public Health,Nutrition and Food Hygiene,Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Anticipated)

September 1, 2020

Study Completion (Anticipated)

December 31, 2020

Study Registration Dates

First Submitted

September 27, 2016

First Submitted That Met QC Criteria

September 27, 2016

First Posted (Estimate)

September 28, 2016

Study Record Updates

Last Update Posted (Actual)

September 13, 2017

Last Update Submitted That Met QC Criteria

September 12, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • ZXYZM-5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

do not share participants data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Disease

3
Subscribe